Complement protein C3 may protect pancreatic beta cells

Survival from pancreatic neuroendocrine tumours improved with surgery

Type-2 diabetes risk lowered by lorcaserin in people who have cardiovascular disease or obesity

08 Oct 2018

Lorcaserin lowers the risk of adults with obesity or cardiovascular disease developing type-2 diabetes, according to research presented at European Association for the Study of Diabetes meeting.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read